This document presents a next-generation sequencing (NGS)-based method for diagnosing COVID-19 using a single-step RNA extraction. The method was tested on 336 clinical samples and showed high accuracy compared to RT-PCR, the gold standard method. Key advantages of the NGS approach include higher scalability allowing thousands of samples to be tested simultaneously, and higher sensitivity to detect SARS-CoV-2 RNA compared to RT-PCR. The method provides individual qualitative results for each patient sample along with viral load estimates based on sequencing coverage.